CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Mar. 31, 2025	Mar. 31, 2024
Income Statement [Abstract]
Revenues	$ 4,185,968	$ 5,242,579	$ 12,909,928	$ 14,388,123
Cost of Goods Sold	3,767,993	3,383,842	10,304,681	9,614,799
Gross Profit	417,975	1,858,737	2,605,247	4,773,324
Research and Development Expenses	211,242	192,773	929,648	627,259
Selling, General and Administrative Expenses	2,245,018	1,924,491	5,870,846	5,514,047
Total Operating Expenses	2,456,260	2,117,264	6,800,494	6,141,306
Operating Income (Loss)	(2,038,285)	(258,527)	(4,195,247)	(1,367,982)
Interest Expense	(58,476)	(58,528)	(182,442)	(172,290)
Net Income (Loss)	$ (2,096,761)	$ (317,055)	$ (4,377,689)	$ (1,540,272)
Income (Loss) Per Share:
Income (Loss) Per Share, Basic	$ (0.30)	$ (0.05)	$ (0.67)	$ (0.25)
Income (Loss) Per Share, Fully Diluted	$ (0.30)	$ (0.05)	$ (0.67)	$ (0.25)
Weighted Average Common Shares Outstanding:
Weighted Average Common Shares Outstanding, Basic	6,917,281	6,068,419	6,491,687	6,067,165
Weighted Average Common Shares Outstanding, Basic, Fully Diluted	6,917,281	6,068,419	6,491,687	6,067,165